NasdaqGS:ISRGMedical Equipment
FDA Cardiac Clearance and Big Buyback Could Be A Game Changer For Intuitive Surgical (ISRG)
In late January 2026, Intuitive Surgical announced that the U.S. FDA cleared its da Vinci 5 system for a range of minimally invasive cardiac procedures, while by December 31, 2025 it had completed a long-running share repurchase totaling 27,136,985 shares for US$7.95 billions.
These developments highlight how Intuitive is pairing major technological advances in high-complexity surgery with substantial capital returns, reinforcing confidence in its innovation-led model.
Next, we’ll examine...